Skip to search.
 STI Down 0.16%

Becton, Dickinson and Company (BDX)

-NYSE
134.89 Down 6.13(4.35%) 2 Sep 04:01 SGT
Add to Portfolio
Prev Close:141.02
Open:138.50
Bid:128.01 x 100
Ask:141.77 x 100
1y Target Est:163.29
Beta:1.2038
Earnings Date:2 Nov - 6 Nov (Est.)
Day's Range:134.29 - 139.23
52wk Range:112.15 - 154.98
Volume:1,791,734
Avg Vol (3m):1,118,050
Market Cap:28.36B
P/E (ttm):33.53
EPS (ttm):4.02
Div & Yield:2.40 (1.64%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
BDXDown 4.35%28.36B
BAXDown 3.17%20.25B
ABTDown 3.80%64.94B

Key Statistics

Forward P/E (1 yr):16.04
P/S (ttm):3.15
Ex-Dividend Date:04-Sep-15

Analysts

Annual EPS Est (Sep-15) :7.11
Quarterly EPS Est (Sep-15) :1.90
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):1.45

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Becton, Dickinson and Company, a medical technology company, develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback